Recent Progress in the Understanding of Angioimmunoblastic T-cell Lymphoma

DOI IR IR (HANDLE) Web Site PubMed 3 Citations 77 References Open Access
  • Fujisawa Manabu
    Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba
  • Chiba Shigeru
    Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba Department of Hematology, Faculty of Medicine, University of Tsukuba Department of Hematology, University of Tsukuba Hospital
  • Sakata-Yanagimoto Mamiko
    Department of Hematology, Graduate School of Comprehensive Human Sciences, University of Tsukuba Department of Hematology, Faculty of Medicine, University of Tsukuba Department of Hematology, University of Tsukuba Hospital

Search this article

Description

<p>Angioimmunoblastic T-cell lymphoma (AITL) has been classified as a subtype of mature T-cell neoplasms. The recent revision of the WHO classification proposed a new category of nodal T-cell lymphoma with follicular helper T (TFH)-cell phenotype, which was classified into three diseases: AITL, follicular T-cell lymphoma, and nodal peripheral T-cell lymphoma with TFH phenotype. These lymphomas are defined by the expression of TFH-related antigens, CD279/PD-1, CD10, BCL6, CXCL13, ICOS, SAP, and CXCR5. Although recurrent mutations in TET2, IDH2, DNMT3A, RHOA, and CD28, as well as gene fusions, such as ITK-SYK and CTLA4-CD28, were not diagnostic criteria, they may be considered as novel criteria in the near future. Notably, premalignant mutations, tumor-specific mutations, and mutations specific to tumor-infiltrating B cells were identified in AITL. Thus, multi-step and multi-lineage genetic events may lead to the development of AITL.</p>

Journal

Citations (3)*help

See more

References(77)*help

See more

Related Projects

See more

Keywords

Details 詳細情報について

Report a problem

Back to top